TARBP2 and adrenal cortex carcinoma: Among ACCs showing a weak TRBP expression, 28 out 73 (38%) ACC patients died during follow-up, whereas 6 out of 7 (86%) ACC patients whose tumors displayed a strong TRBP expression died during follow-up.